We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal

Download Mobile App




Events

31 Jul 2024 - 02 Aug 2024
02 Aug 2024 - 04 Aug 2024
20 Aug 2024 - 22 Aug 2024

AI-Powered Cardiac Device Identifies Potential Heart Issues Before They Become Life-Threatening

By HospiMedica International staff writers
Posted on 15 Sep 2023
Print article
Image: The cutting-edge non-invasive diagnostic tool could transform cardiovascular care (Photo courtesy of 123RF)
Image: The cutting-edge non-invasive diagnostic tool could transform cardiovascular care (Photo courtesy of 123RF)

Nearly one-third of all heart attacks show no symptoms, and for over half of the people who suffer from cardiac-related fatalities, the first warning sign is the heart attack itself. Unfortunately, most individuals don't seek medical help until they notice symptoms or actually experience a heart attack. Now, the world’s first early detection device for heart disease and other underlying cardiac issues is poised to revolutionize the field of cardiovascular care.

Forum Health (Flint, MI, USA) has rolled out its Multifunction Cardiogram (MCG) scan aimed at the early detection of heart disease and cardiac abnormalities. Designed as a preventive tool, the MCG scan is intended for both young and general populations who face an increased risk of heart disease. In contrast to traditional diagnostic approaches that wait for symptoms to appear, the MCG scan leverages cutting-edge artificial intelligence (AI) to identify a broad spectrum of heart-related issues. The system becomes more intelligent with each scan, making it the most thorough and precise heart assessment tool currently available.

Taking an MCG test is as simple as undergoing a 10-minute resting EKG, requiring no preparation from the patient. All the individual needs to do is lie still and relax while the device scans and gathers data about their heart. Specifically, the MCG evaluates how effectively blood is circulating into and out of the heart, as well as the overall health of the heart muscle. This collected data is then sent to a server where it's compared against a database featuring 200,000 patients with confirmed cardiovascular disease, as validated by angiograms. The MCG algorithm then gauges the patient's data against these established cases and produces an objective score ranging from 0 to 22 to measure heart dysfunction—the lower the score, the better the heart's condition. A detailed diagnostic report is then generated and shared securely with the attending physician. This report outlines whether the patient shows signs of local ischemia, global ischemia, or both, along with 26 other indicators of possible disease and inflammation.

"The MCG scan is a revolutionary cardiac device,” said Dr. Steven Meress, Forum Health Fond du Lac. “In March 2023, we performed the first round of scans; five months later, 12 out of 12 follow-up scans show improvement. This evidence shows how effective early interventions can be when based off the MCG scan and the positive impact on cardiac health."

Related Links:
Forum Health 

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Portable Single Breath DLCO Device
EasyOne Pro

Print article

Channels

Surgical Techniques

view channel
Image: Fixation screws for ligament to bone repair (Photo courtesy of 4D Medicine)

Novel Biomaterial Platform Opens Up New Possibilities for Implants and Devices

Resorbable biomaterials, crucial for implantable medical devices, have seen little innovation over decades. Materials like Polylactic Acid (PLA), Polycaprolactone (PCL), and Poly Lactic-co-Glycolic Acid... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more

Business

view channel
Image: The Innovalve transseptal delivery system is designed to enable safe deployment of the Innovalve implant (Photo courtesy of Innovalve Bio)

Edwards Lifesciences Acquires Sheba Medical’s Innovalve Bio Medical

Edwards Lifesciences (Irvine, CA, USA), a leading company in medical innovations for structural heart disease and critical care, has acquired Innovalve Bio Medical LTD. (Ramat Gan, Israel), an early-stage... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.